Log In
BCIQ
Print this Print this
 

IPP-102199

  Manage Alerts
Collapse Summary General Information
Company ImmuPharma plc
DescriptionOral analgesic
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat post-operative pain; Treat severe cancer pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today